prior to now few years, the UK has witnessed a revolution in professional medical excess weight‑reduction treatment plans — in the introduction of semaglutide (Wegovy®) to the rising acceptance of tirzepatide (Mounjaro®). Now, An additional identify is drawing attention in both scientific and gen